Evidence map›Paper›PMID 36568184›Full record

ArticleFrontiers in oncology2022

Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia.

Wenshuai Zheng, Yamei Wu, Lixun Guan, Longcan Cheng, Yalei Hu, Min Tan, Yuhui Yang, Hongmei Ning

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wenshuai ZhengDepartment of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.
Yamei WuDepartment of Hematology, Seventh Medical Center of Chinese PLA General Hospital, Beijing, China.
Lixun GuanDepartment of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.
Longcan ChengDepartment of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.
Yalei HuDepartment of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.
Min TanDepartment of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.
Yuhui YangDepartment of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.
Hongmei NingSenior Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNHainan General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For acute leukemia (AL) with adverse prognostic factors, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the standard care option after the first complete remission. Meanwhile, as the success of haploidentical HSCT (haplo-HSCT), haploidentical donors (HIDs) become a reliable choice. However, there have been no reports on haplo-HSCT from HIDs with mild alpha(α)-thalassemia for AL yet. In the present report, we first describe two cases of successful haplo-HSCT from HIDs with mild α-thalassemia for AL.

Indexed as

acute leukemiahaploidentical allogeneic hematopoietic stem cell transplantationhaploidentical donorssuccessfulthalassemia

Identifiers

PMID36568184
PMCPMC9773128
OpenAlexW4311861640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.